Clinical Trial Update: A Study of HX008 for the Treatment of Patients With Metastatic Triple Negative Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for HX008 in metastatic triple-negative breast cancer across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• HX008

Snippet

Sponsor: Taizhou Hanzhong biomedical co. LTD | Conditions: Triple-negative Breast Cancer | Phase 1, Phase 2 | Status: UNKNOWN